Madrigal Pharmaceuticals Inc
XNAS: MDGL
Madrigal Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart
about
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver f...
Read More
453.80
20.91
(4.83%)
652.7K
XNAS Volume
XNAS 08 Sep, 2025 5:30 PM (EDT)
Board Meeting
The latest board meeting for Madrigal Pharmaceuticals Inc took place on 08 Sep 2025, for the purpose of Morgan Stanley 23(rd) Annual Global Health Care Conference
See details
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Madrigal Pharmaceuticals Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..